Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all ...

FDA advisory panel to vote on COVID-19 vaccine strains for 2025-2026 campaign amid uncertainty over dominant variants.

The variant, first detected in the U.S. in late March, has now been identified in arriving international travelers through ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

Government advisers debate updating COVID-19 vaccines for next season amid confusion over new U.S. policy on booster shots.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

The NB.1.8.1 COVID-19 variant, dominant in China, is spreading in the U.S. via international travelers, with cases detected ...

At the outset of the meeting, the FDA's new top vaccine regulator, Vinay Prasad, said he and FDA leaders wanted to "give people a little more time to digest the policy." He said that the FDA is still ...